Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. on Investment Edge’s Substack by David Vicuña. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers Health Inc. (HIMS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 4,818,009 | $156,440,752 | -48% | 0.24% |
| 2. | 1,889,000 | $61,335,830 | +410% | 0.07% | |
| 3. | 694,000 | $22,534,180 | -11% | 0.02% | |
| 4. | 546,800 | $17,754,596 | +136% | 0.05% | |
| 5. | Walleye Capital Will England | 379,764 | $12,330,937 | +289% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.50 | 1,000 | $24,500.00 | 5,000 | 2024-11-14 | Filing | |
| $26.94 | 4,000 | $107,759.60 | 4,000 | 2024-11-12 | Filing | |
| $17.74 | 110,000 | $1,951,763.00 | 110,000 | 2024-05-21 | Filing | |
| $3.66 | 73,700 | $269,742.00 | 125,000 | 2022-06-14 | Filing | |
| $3.66 | 1,300 | $4,751.50 | 51,300 | 2022-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $26.44 | 5,262 | $139,107.81 | 91,617 | 2026-02-03 | Filing | |
| $30.34 | 9,067 | $275,113.63 | 91,617 | 2026-01-20 | Filing | |
| $33.79 | 9,070 | $306,452.63 | 91,617 | 2026-01-05 | Filing | |
| $35.72 | 23,090 | $824,710.15 | 94,333 | 2025-12-22 | Filing | |
| $36.71 | 13,750 | $504,762.50 | 305,161 | 2025-12-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 26,573,504 | $862,841,675 | 0.01% | |
| 2. | 20,925,666 | $679,456,374 | 0.01% | |
| 3. | 18,838,270 | $611,678,662 | 0.04% | |
| 4. | 14,322,912 | $465,068,856 | 0.06% | |
| 5. | 10,347,343 | $335,978,228 | 0.04% |
News See All
BofA Maintains an Underperform Rating on Hims & Hers Health, Inc. (HIMS)
TheFly reported on January 8, 2026, that BofA reduced the price target for Hims & Hers Health, Inc. (NYSE:HIMS) to $29 from $32. It retained an Underperform rating on the stock.
7 Best Beauty Stocks to Buy Right Now
According to NielsenIQ, men's grooming sales in the US jumped by 6.9% year over year to $7.1 billion in 2025.
Hims & Hers Health (HIMS) Fell Due to Increased Regulatory Challenges
Maple Tree Capital, an investment management company, released its Q3 2025 investor letter. A copy of the letter can be downloaded here. The third quarter was mixed for Maple Tree Capital.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. on Investment Ideas by Antonio’s Substack by Antonio Linares. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2025 Earnings Call Transcript
Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2025 Earnings Call Transcript November 3, 2025Hims & Hers Health, Inc. reports earnings inline with expectations.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. on Business Ontology’s Substack by Lorenzo Bastianelli. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers (HIMS) Soars 16% as Firm On Track to Book $1 Billion Revenues from Women Segment
Hims & Hers soared by 16.18 percent on Wednesday to end at $62.76 apiece as investors cheered the company’s optimism that it would surpass its $1 billion revenue target from women’s health alone in...
Hims & Hers (HIMS) Jumps on Leadership Changes, Global Initiatives
In a social media post over the weekend, Hims & Hers Health Inc.
16 Stocks Jim Cramer Recently Talked About
“I want you to keep in mind that September is a pivotal month for the sportsbooks because it marks the start of the football season. It's make or break for these companies….
Hedge Fund Resource Center Billionaire Hedge Funds
